Comorbid Chronic Inflammatory Diseases Influence Alopecia Areata Prognosis
By Elana Gotkine HealthDay Reporter
TUESDAY, Jan. 28, 2025 -- Comorbid chronic inflammatory diseases (CIDs) influence the prognosis of alopecia areata (AA), according to a research letter published online Jan. 8 in Allergy.
Annika Friedrich, from the University of Bonn in Germany, and colleagues used self-reported data from 2,657 mainly Central European AA patients to conduct a comprehensive analysis of associations between comorbid CIDs and selected AA-clinical features of relevance to prognosis.
Overall, 53.7 percent of the AA cohort reported one or more comorbid CID of any type: 44.5 and 17.4 percent reported one or more comorbid atopic CID and nonatopic CID, respectively. The researchers found that compared with patients with no comorbid CIDs, those with comorbid atopic dermatitis (AD), bronchial asthma, or Hashimoto thyroiditis were significantly more likely to report early-onset, severe, and prolonged AA. A significantly increased risk for prolonged AA was seen for patients with comorbid rhinitis or vitiligo. Compared with comorbid AD or rhinitis, comorbid bronchial asthma was associated with a higher risk for early-onset, severe, or prolonged AA. A more pronounced association was seen for CID comorbidity status with AA duration than with age of onset or severity. A significantly higher number of self-reported atopic comorbidities was seen in early-onset, severe, and prolonged AA compared with late-onset, mild, and nonprolonged disease, respectively. Per additional atopic comorbidity, the odds of early-onset, severe, and prolonged AA increased by 1.179, 1.130, and 1.202, respectively. The mean age of onset for AA was almost 10 years earlier in patients with AD + bronchial asthma + rhinitis compared with patients with AA only.
"Our findings suggest that distinct comorbid constellations may indicate AA subtypes with differing prognoses," the authors write.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Posted January 2025
Read this next
Severe Exacerbations Down With As-Needed Albuterol-Budesonide for Mild Asthma
FRIDAY, May 23, 2025 -- As-needed albuterol-budesonide yields a lower risk for severe asthma exacerbation among patients with mild asthma, according to a study published online...
Asthma Attacks Increase for Some Women Taking Progestogen-Only Pill
THURSDAY, May 8, 2025 -- Use of a combined oral contraceptive (COC) is not associated with asthma in women of reproductive age, but use of a progestogen-only pill (POP) is...
Scalable Symptom Monitoring Intervention May Up Asthma-Related QoL in Subgroup of Adults
THURSDAY, May 8, 2025 -- A scalable symptom monitoring intervention increases asthma-related quality of life in adults, according to a study published online April 23 in JAMA...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.